
900181851 | BTOMMC | 05179465 | | 3382592 | 2/13/2006 12:00:00 AM | flash pulmonary edema | | DIS | Admission Date: 5/26/2006 Report Status:

Discharge Date: 5/25/2006
****** FINAL DISCHARGE ORDERS ******
DERRICK , DANNY 522-03-89-2
S Ox
Service: CAR
DISCHARGE PATIENT ON: 10/1/06 AT 03:00 PM
CONTINGENT UPON Attending evaluation
WILL D/C ORDER BE USED AS THE D/C SUMMARY: YES
Attending: STOHS , MICHALE DANA , M.D.
CODE STATUS:
Full code
DISPOSITION: Home w/ services
DISCHARGE MEDICATIONS:
ALLOPURINOL 100 MG PO DAILY
Alert overridden: Override added on 10/28/06 by
TOOKES , RANDALL S. , M.D. , PH.D.
SERIOUS INTERACTION: WARFARIN & ALLOPURINOL
Reason for override: Md aware
ENTERIC COATED ASPIRIN ( ASPIRIN ENTERIC COATED )
81 MG PO DAILY
Override Notice: Override added on 10/28/06 by
HASHA , RORY M. , M.D. , PH.D.
on order for COUMADIN PO ( ref # 071446592 )
POTENTIALLY SERIOUS INTERACTION: ASPIRIN & WARFARIN
Reason for override: md aware
LASIX ( FUROSEMIDE ) 80 MG PO DAILY
Starting Today ( 1/3 )
LEVOXYL ( LEVOTHYROXINE SODIUM ) 100 MCG PO DAILY
Alert overridden: Override added on 10/28/06 by
LABKOVSKY , WESTON T. , M.D. , PH.D.
SERIOUS INTERACTION: WARFARIN & LEVOTHYROXINE SODIUM
Reason for override: md aware
LISINOPRIL 2.5 MG PO DAILY
PRAVACHOL ( PRAVASTATIN ) 40 MG PO BEDTIME
Food/Drug Interaction Instruction
Avoid grapefruit unless MD instructs otherwise.
Override Notice: Override added on 10/28/06 by
CHARTRAW , NOE G. , M.D. , PH.D.
on order for NIASPAN PO ( ref # 570641766 )
POTENTIALLY SERIOUS INTERACTION: PRAVASTATIN SODIUM &
NIACIN , VIT. B-3 Reason for override: md aware
Previous override information:
Override added on 10/28/06 by ROYSTER , HARLAN C. , M.D. , PH.D.
on order for COUMADIN PO ( ref # 071446592 )
POTENTIALLY SERIOUS INTERACTION: PRAVASTATIN SODIUM &
WARFARIN Reason for override: md aware
TOPROL XL ( METOPROLOL SUCCINATE EXTENDED RELEASE )
50 MG PO DAILY Food/Drug Interaction Instruction
Take consistently with meals or on empty stomach.
Number of Doses Required ( approximate ): 1
NIASPAN ( NICOTINIC ACID SUSTAINED RELEASE )
0.5 GM PO DAILY
Alert overridden: Override added on 10/28/06 by
HANSERD , WALTON T. , M.D. , PH.D.
POTENTIALLY SERIOUS INTERACTION: PRAVASTATIN SODIUM &
NIACIN , VIT. B-3 Reason for override: md aware
NEXIUM ( ESOMEPRAZOLE ) 20 MG PO DAILY
GLIPIZIDE 5 MG PO BID
DIET: Fluid restriction
DIET: House / Low chol/low sat. fat
DIET: House / ADA 1800 cals/dy
DIET: 2 gram Sodium
ACTIVITY: Resume regular exercise
FOLLOW UP APPOINTMENT( S ):
CARD DR SIMAO ( 389 ) 710-9257 ( call office to make appt ) scheduled ,
CV Surgery Dr. Harrison Skeete at 220-7697 ( call next week for appt. ) ,
ALLERGY: NKA
ADMIT DIAGNOSIS:
pulmonary edema
PRINCIPAL DISCHARGE DIAGNOSIS ;Responsible After Study for Causing Admission )
flash pulmonary edema
OTHER DIAGNOSIS;Conditions , Infections , Complications , affecting Treatment/Stay
CHF ( congestive heart failure ) cad ( coronary artery disease ) htn
( hypertension ) dm ( diabetes mellitus ) gerd ( gastroesophageal reflux
disease ) hypothyroidism ( hypothyroidism ) mitral regurgitation
( 2 ) lung ca s/p lobectomy ( lung cancer ) endometrial ca s/p TAH/BSO
( endometrial cancer ) basal cell ca ( basal cell
carcinoma ) CRI ( chronic renal dysfunction ) renal artery stenosis s/p
L stent ( renal artery stenosis ) recurrent flash pulm edema ( pulmonary
edema )
OPERATIONS AND PROCEDURES:
none
OTHER TREATMENTS/PROCEDURES ( NOT IN O.R. )
none
BRIEF RESUME OF HOSPITAL COURSE:
CC: CHF
HPI: 75F with iCMP , CAD s/p MI s/p multiple stents to LAD , LCx ,
moderate/severe MR with multiple recent presentations for
decompensated CHF , h/o recurrent bronchoalveolar Ca , stage IV , 1 wk
h/o increased lasix requirements with increased dyspnea , several
episodes of PND. On the AM of admission she p/w SOB , dyspnea , all not
relieved by NTG or lasix. She presented to FWH ED with BP 173/74 , HR
112 , admitted and transferred to XMH .  At baseline ambulates 1.5
blocks flat ground , stops 2/2 DOE , never uses stairs. anginal
equivalent of throat/jaw discomfort.
PMH: CAD s/p MI , mult stents to LAS , LCx , mod-severe MR , iCMP , high
chol , HTN , DM , PAF , PVD s/p RAS stenting , uterine CA s/p TAH/BSO
2004 , ACD , CRI baseline Cr 2.0 , stage IV NSCLC ( T4NxM1 ) , recurrent.
ALL: NKDA
MEDS: lisinoptil 2.5 , pravachol 40 , asa 81 ,
coumadin 2 , niaspan 500 , lasix 80qam 40qpm , metoprolol 25mg po bid ,
levoxyl 100mcg , allopurinol 100 , nexium 20 , glipizide 5mg qam mg
qpm
SH: former smoker , 30py , no EtOH no IVDU
EXAM: 96.6 97 112/48 22 100%
( 3L ) NAD JVP 9 bibasilar rales s1 s2 iii/vi SEM ii/vi
HSM abd benign ext warm no edema dp2+ bilat. a&ox3 STUDIES:
ECHO 9/19 EF 40% mild cLVH mid/dist sept apex AK , mod surrounding
HK , mild LAE , mod/severe central MR , trace TR , PA 41+
RVP. CATH: 2001: LAD 60% OM2 100% RCA 40% collaterals
RLV->OM2 MIBI 3/14 adenosine , limited by soft tissue ,
large sie moderate intensity fixed basal/inf/septal defect
UA: 2+ prot , neg nit/le/wbc EKG 10/22 ( ARMC ) sinus tachy , incomplete
LBBB , leftward axis deviation , 1st deg AVB , 1mmST dep
v5/v6 , TWI L/I/6 CXR 10/22 ( BH ) AP , mod pulm edema , postop
changes chem 7 wnl , INR 2.1 , CC wnl , enzymesflat
IMPRESSION:
75F with iCMP , mod-sev MR , recurrent stage IV bronchoalveolar lung Ca p/w
decompensated CHF.
HOSPTIAL COURSE BY SYSTEM
( 1 ) CV: Ischemia: a/b/c sets negative so ruled out for an MI. ETT 4.4 mets ,
Baseline ST changes in inferior and lateral leads limits specificity.
ASA , BB , statin , ACE continued. Cath ( 10/10 ) showed:
Left Main Coronary Artery
No significant LM lesions identified
Left Anterior Descending Artery
LAD ( Proximal ) , Generic 50% lesion
Left Circumflex Artery
CX ( Mid ) , Generic 80% lesion
Right Coronary Artery
RCA ( Ostial ) , Generic 40% lesion
RCA ( Mid ) , Generic 50% lesion
Moderate , non-severe CAD. A 50% mid LAD , a small true AV groove LCX with a
70-80% , a 40% ostial RCA with a mid vessel 50% stenosis. PUMP: flash
pulmonary edema of unknown origin no longer volume overloaded
after diuresis in SMCMC ED and at TWMC .  Mild diuresis by ayugmenting pm
dose lsix to 80 while hospitalized , returned to 80qd prior to discharge.
Main change in regimen is that we reduced lasix dose to 80 qd PO Lasix.
MIBI On the day of discharge. Pt. was assessed by cardiac surgery for MVR
+/- CABG , but prior to surgery dental evaluation suggested possible
extraction; OR date cancelled , pt. received dental films 4/8 , cleared for
OR , will go home 4/8 and patient will follow up with Dr.
Svensen of Cardiac Surgery for scheduling of palliative MVR. Pt will also
buy a home BP monitor so as to self check her
BP when short of breath to see if the HTN comes first or after.
RHYTHM: NSR , on tele , replete lytes
( 2 ) PULM: no O2 requirement
( 3 ) RENAL: baseline CRI , followed creatinine bid while diuresing
( 4 ) ONC: bronchoalveolar Ca stable per primary oncologist. Discussed with
Dr. Heiro .
( 5 ) FEN: cardiac ADA 2g salt 2L fluid restrict. Aggressive K
repletion
( 6 ) Ppx: INR therapeutic for majority of hospitaliation , nexium ( off
coumadin for INR<2.0 for
catheterization , holding coumadin after d/c for anticipated cardiac
surgery ).
( 7 ) FULL CODE ( has been DNR/DNI before )
ADDITIONAL COMMENTS: You have been cleared for cardiac surgery , please follow up with Dr.
Ruben Rodeman in the next week to schedule a date. Please call Dr.
Whitegoat office or present to the ED with any worsening of symptoms.
DISCHARGE CONDITION: Stable
TO DO/PLAN:
--d/c to home on prior regimen exceopt lasix dose changed to 80mg qd ,
holding coumadin in anticipation of cardiac surgery
--f/u with Dr. Windschitl , cardiac surgery , on Monday
--use of lasix/NTG if episodic SOB
--f/u with Roscoe Perow
--per dental , should cover with clinda as prophylaxis during cardiac
surgery
No dictated summary
ENTERED BY: MUTCHLER , DUANE N. , M.D. , PH.D. ( PN620 ) 10/1/06 @ 03:41 PM
****** END OF DISCHARGE ORDERS ******